Strs Ohio Invests $1.86 Million in Henry Schein, Inc. $HSIC

Strs Ohio purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 27,141 shares of the company’s stock, valued at approximately $1,859,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Acadian Asset Management LLC bought a new position in Henry Schein during the 1st quarter worth approximately $676,000. IFM Investors Pty Ltd increased its holdings in Henry Schein by 6.6% during the 1st quarter. IFM Investors Pty Ltd now owns 23,831 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,482 shares in the last quarter. Focus Partners Wealth boosted its stake in shares of Henry Schein by 1.8% during the 1st quarter. Focus Partners Wealth now owns 32,241 shares of the company’s stock worth $2,208,000 after buying an additional 560 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in Henry Schein in the 1st quarter valued at about $103,000. Finally, MBB Public Markets I LLC acquired a new stake in Henry Schein in the 1st quarter valued at about $308,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $68.39 on Wednesday. The company’s 50 day simple moving average is $69.12 and its 200 day simple moving average is $69.41. The stock has a market capitalization of $8.29 billion, a price-to-earnings ratio of 22.06, a price-to-earnings-growth ratio of 2.27 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period last year, the business earned $1.23 earnings per share. The business’s revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HSIC. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Sunday, September 7th. UBS Group cut their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Baird R W cut shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Finally, Leerink Partners set a $75.00 target price on shares of Henry Schein in a report on Monday, July 14th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.